Luye Pharma Group (HKG:2186) reported 312.9 million yuan in attributable profit for the first half of 2025, falling 19% from 387.8 million yuan a year earlier, according to a Hong Kong bourse filing Thursday.
Earnings per share was 0.0832 yuan, compared with 0.1031 yuan in the prior year.
Revenue rose 3.5% year-on-year to 3.18 billion yuan, figures showed.
Shares of the pharma company gained 8.1% in afternoon trade Friday.